Imam Abdulrahman Bin Faisal University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Dammam Saudi Arabia (1975)

Organization Overview

First Clinical Trial
2009
NCT01564680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Associate professor university of Dammam | College of Medicine, Imam Abdulrahman Bin Faisal University | Dammam University | Emergency and Critical Care Medicine Consultant Director, Critical Care Medicine Department Medical Director, King Fahad Hospital of the University Associate Professor - College of Medicine Imam Abdulrahman Bin Faisal University - (Dammam University) | Imam Abdulrahman Al Faisal Hospital | imam Abdulrahman Bin Faisal | Imam Abdulrahman Bin Faisal University | Khalood Saeed Bahammam | Mohammed Al-Ghamdi | Turki Abualait | University of Dammam | University of Dammam, Dammam, Saudi Arabia | University of Dammam, Saudi Arabia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Cardiovascular Diseases (Phase 4)

Chest Pain (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Embolism (Phase 4)

Heart Diseases (Phase 4)

Infarction (Phase 4)

Muscle Hypotonia (Phase 2)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Otorhinolaryngologic Diseases (Phase 4)

Pain, Postoperative (Phase 4)

Sinusitis (Phase 4)

Thrombosis (Phase 4)

Vascular Diseases (Phase 4)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 29